Annual Operating Expenses
$167.74 M
+$7.74 M+4.84%
31 December 2023
Summary:
BioXcel Therapeutics annual total operating expenses is currently $167.74 million, with the most recent change of +$7.74 million (+4.84%) on 31 December 2023. During the last 3 years, it has risen by +$85.44 million (+103.82%). BTAI annual operating expenses is now at all-time high.BTAI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$12.78 M
-$4.70 M-26.87%
30 September 2024
Summary:
BioXcel Therapeutics quarterly total operating expenses is currently $12.78 million, with the most recent change of -$4.70 million (-26.87%) on 30 September 2024. Over the past year, it has dropped by -$31.18 million (-70.92%). BTAI quarterly operating expenses is now -75.94% below its all-time high of $53.12 million, reached on 31 December 2022.BTAI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.8% | -70.9% |
| 3 y3 years | +103.8% | -52.3% |
| 5 y5 years | +740.3% | +40.0% |
BTAI Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +103.8% | -75.9% | at low |
| 5 y | 5 years | at high | +740.3% | -75.9% | +52.0% |
| alltime | all time | at high | +7812.2% | -75.9% | +2316.6% |
BioXcel Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.78 M(-26.9%) |
| June 2024 | - | $17.48 M(-29.1%) |
| Mar 2024 | - | $24.66 M(+26.2%) |
| Dec 2023 | $167.74 M(+4.8%) | $19.54 M(-55.6%) |
| Sept 2023 | - | $43.96 M(-16.8%) |
| June 2023 | - | $52.84 M(+2.8%) |
| Mar 2023 | - | $51.40 M(-3.3%) |
| Dec 2022 | $160.00 M(+49.6%) | $53.12 M(+35.8%) |
| Sept 2022 | - | $39.12 M(+7.8%) |
| June 2022 | - | $36.29 M(+15.3%) |
| Mar 2022 | - | $31.48 M(+20.5%) |
| Dec 2021 | $106.94 M(+29.9%) | $26.13 M(-2.5%) |
| Sept 2021 | - | $26.81 M(-2.9%) |
| June 2021 | - | $27.61 M(+4.7%) |
| Mar 2021 | - | $26.38 M(+25.0%) |
| Dec 2020 | $82.30 M | $21.10 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $24.77 M(+15.5%) |
| June 2020 | - | $21.43 M(+42.9%) |
| Mar 2020 | - | $15.00 M(+78.2%) |
| Dec 2019 | $33.60 M(+68.3%) | $8.41 M(-7.9%) |
| Sept 2019 | - | $9.13 M(+5.8%) |
| June 2019 | - | $8.63 M(+16.4%) |
| Mar 2019 | - | $7.42 M(+1.4%) |
| Dec 2018 | $19.96 M(+340.0%) | $7.31 M(+42.9%) |
| Sept 2018 | - | $5.12 M(+57.8%) |
| June 2018 | - | $3.24 M(-24.3%) |
| Mar 2018 | - | $4.29 M(+69.7%) |
| Dec 2017 | $4.54 M(+114.0%) | $2.53 M(+175.5%) |
| Sept 2017 | - | $917.00 K(+62.3%) |
| June 2017 | - | $565.00 K(+6.8%) |
| Mar 2017 | - | $529.00 K |
| Dec 2016 | $2.12 M | - |
FAQ
- What is BioXcel Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual operating expenses year-on-year change?
- What is BioXcel Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly operating expenses year-on-year change?
What is BioXcel Therapeutics annual total operating expenses?
The current annual operating expenses of BTAI is $167.74 M
What is the all time high annual operating expenses for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual total operating expenses is $167.74 M
What is BioXcel Therapeutics annual operating expenses year-on-year change?
Over the past year, BTAI annual total operating expenses has changed by +$7.74 M (+4.84%)
What is BioXcel Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BTAI is $12.78 M
What is the all time high quarterly operating expenses for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly total operating expenses is $53.12 M
What is BioXcel Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BTAI quarterly total operating expenses has changed by -$31.18 M (-70.92%)